# US 2003/0225067 A1 · Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (CNS) and/or in other parenchymal organs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0225067 A1
- Document ID: US20030225067A1
- Status: Published application
- Kind: A1
- Application number: 10/392,299
- Filed: 2003-03-20
- Published: 2003-12-04
- Earliest claimed: 1999-06-04
- Inventors: Ruediger Stendel; Rolf W. Pfirrmann
- Web page: https://patentgrep.com/patent/US20030225067A1

## CPC

- A61M 37/00: Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04)
- A61B 5/14525: {using microdialysis}
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 31/54: having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K 31/549: having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A61K 38/2006: {IL-1}
- A61K 38/2013: {IL-2}
- A61K 38/21: Interferons {[IFN]}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61M 2025/0042: {Microcatheters, cannula or the like having outside diameters around 1 mm or less}
- A61M 2025/0057: {Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings}
- A61M 2210/0693: Brain, cerebrum
- A61M 2210/1003: Spinal column
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates, e.g., to a method and application for the treatment and/or prophylaxis of tumors and/or infections in the central nervous system and/or other parenchymal organs in mammalian subjects. In preferred embodiments, a microdialysis device is used to provide an effective dose of taurolidine and/or its metabolites and/or other chemotherapeutic and/or immunotherapeutic and/or antibiotic and/or virostatic and/or fungistatic agents is administed to a mammalian subject suffering from or at risk to growth of tumors of the central nervous system and/or other parenchymal organs.

## Claims

### Claim 1

An apparatus for use inserting into a patient so as to provide access to the central nervous system (CNS) or another parenchymal organ for administering a dose of a tumor or infection inhibiting methylol transfer agent to a mammalian subject, comprising:
an elongated microprobe having a lumen through which a solution can be pumped from a reservoir;
said microprobe having a semipermeable region through which a dose of CNS tumor or infection inhibiting methylol transfer agent will pass when the solution is pumped into said microprobe to a region of a tumor and/or infection.

### Claim 2 (depends on 1)

The apparatus of claim 1, further including:
a solution having a methylol transfer agent;
a reservoir containing said solution; and
a pump for pumping said solution into said microprobe via said lumen.

### Claim 3 (depends on 1)

The apparatus of claim 1, wherein said microprobe includes a return path around said lumen and said semipermeable region is along said return path.

### Claim 4 (depends on 1)

The apparatus of claim 1, wherein said agent is Taurolidine, Taurultam or a mixture thereof.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein said agent is Taurultam-glucose.

### Claim 6 (depends on 1)

The apparatus of claim 1, wherein said semipermeable region includes a tube bundle.

### Claim 7 (depends on 1)

The apparatus of claim 1, wherein said semipermeable region includes a semipermeable membrane.

### Claim 8 (depends on 1)

The apparatus of claim 1, wherein said lumen extends substantially concentrically within said microprobe.

### Claim 9 (depends on 8)

The apparatus of claim 8, wherein said lumen extends concentrically beneath said semipermeable region.

### Claim 10 (depends on 1)

The apparatus of claim 1, wherein said apparatus is for use inserting into a patient so as to provide access to the central nervous system.

### Claim 11 (depends on 1)

The apparatus of claim 1, wherein said apparatus is for use inserting into a patient so as to provide access to a parenchymal organ outside of the central nervous system.

### Claim 12

An apparatus for use inserting into a patient so as to provide access to the central nervous system or another parenchymal organ for an agent, comprising:
a microprobe having a length and a width, said length being substantially longer than said width;
said microprobe having a lumen extending lengthwise in the microprobe, said lumen having an opening proximate a distal end of the microprobe;
said microprobe having a return path extending from said opening of said lumen to a base end of the microprobe;
said microprobe having a semipermeable region around at least a portion of said return path;
a reservoir for containing a solution having the agent;
a pump for pumping the solution from said reservoir, into said lumen and into said return path;
whereby the microprobe can administer the agent through said semipermeable region locally to a region of a tumor and/or infection.

### Claim 13 (depends on 12)

A method of treating central nervous system or other parenchymal organ tumors and/or infections comprising inserting the apparatus of claim 12 so as to administer to the central nervous system or other parenchymal organ an agent, the apparatus comprising:
a microprobe having a length and a width, said length being substantially longer than said width;
said microprobe having a lumen extending lengthwise in the microprobe, said lumen having an opening proximate a distal end of the microprobe;
said microprobe having a return path extending from said opening of said lumen to a base end of the microprobe;
said microprobe having a semipermeable region around at least a portion of said return path;
a reservoir for containing a solution having the agent;
a pump for pumping the solution from said reservoir, into said lumen and into said return path;
whereby the microprobe can administer the agent through said semipermeable region locally to a region of a tumor and/or infection.

### Claim 14 (depends on 13)

The method of claim 13, wherein said agent is Taurolidine, Taurultam or a mixture thereof.

### Claim 15 (depends on 13)

The method of claim 13, wherein said agent is Taurultam-glucose.

### Claim 16 (depends on 13)

The method of claim 13, wherein said semipermeable region includes a tube bundle.

### Claim 17 (depends on 13)

The method of claim 13, wherein said semipermeable region includes a semipermeable membrane.

### Claim 18 (depends on 13)

The method of claim 13, wherein said lumen extends substantially concentrically within said microprobe.

### Claim 19 (depends on 18)

The method of claim 18, wherein said lumen extends concentrically beneath said semipermeable region

### Claim 20 (depends on 13)

The method of claim 13, wherein said apparatus is inserted into a patient so as to provide access to the central nervous system.

### Claim 21 (depends on 13)

The method of claim 13, wherein said apparatus is inserted into a patient so as to provide access to a parenchymal organ outside of the central nervous system.
